Pioneering a Revolution in Genomic Research: MGI Partners with Xpress Genomics

In a significant move within the life science industry, MGI, recognized as a global frontrunner in life science technology, has forged a strategic alliance with Xpress Genomics, a pioneering Stockholm-based entity renowned for its advanced RNA-sequencing strategies. This partnership is poised to catapult genomics research into unprecedented territories by integrating state-of-the-art technologies to craft scalable and efficient solutions for deep single-cell RNA-sequencing (scRNA-seq), a technique pivotal for understanding cellular functions in complex biological systems.

About Xpress Genomics

At the helm of Xpress Genomics is Prof. Rickard Sandberg, alongside CEO Dr. Christoph Ziegenhain and a cadre of impassioned researchers. The company has swiftly ascended to the forefront of the industry, championing the development of scalable single-cell RNA-sequencing methodologies. Xpress Genomics stands out for its commitment to maintaining the integrity of quality and coverage, ensuring that its scRNA-seq solutions offer unparalleled sensitivity across entire transcripts. This technological prowess facilitates comprehensive analyses of marker genes, genetic variations, and splicing events, thereby enabling large-scale genomic studies.

Prof. Sandberg's enthusiasm about the collaboration reflects the potential impact of this alliance, "We are thrilled at the prospect of merging our expertise with MGI's sequencing prowess to bring forth the most cost-effective and scalable full-length scRNA-seq solutions to date."

A Partnership with Vision

The synergy between MGI and Xpress Genomics is driven by a mutual ambition to transcend the current limits of single-cell genomics. Duncan Yu, President of MGI, articulated the strategic significance of this collaboration, emphasizing MGI's dedication to equipping the global scientific community with cutting-edge tools that foster industry advancement. Ming Ni, MGI's Vice President, further underscored the transformative nature of single-cell RNA-sequencing and MGI's commitment to supporting Xpress Genomics in overcoming the inherent challenges of single-cell sequencing.